LMP Capital and Income Fund Inc. (SCD)

Montreal, QC – TheNewswire - September 25, 2025 — Scandium Canada Ltd. (TSXV:SCD) (OTC:SCDCF) is pleased to announce that new data on the properties of its modified AA535 and AA7075 alloys confirm an economically viable technological advancement in the field of aluminum-scandium (Al-Sc) alloys explicitly developed for additive manufacturing applications. The current results are focused on the properties of samples printed through the laser powder-bed fusion (L-PBF) process. The company's latest results substantiate that Scandium Canada's alloys offer a practical solution to one of the most persistent challenges in metal 3D printing: eliminating cracking in high-strength aluminum alloys, which paves the way for a new era of lightweight, high-performance, and cost-effective components across multiple industries. See press release : Scandium Canada updates on aluminum-scandium 3D powders research and development . It should be noted that Scandium Canada has established a division within the company, Scandium + , dedicated explicitly to ramp up commercialization efforts for these two Al-Sc powders and the development of other Al-Sc alloys, to engage in dialogue with end-users. Press release : Scandium Canada Ltd. makes changes to its management team and corporate structure .   Scandium + 's main objectives are to :

We've got a frankly, bizarre dynamic setting up in stocks right now.

LMP Capital and Income Fund Inc. is a multi-sector hybrid fund that invests in a fairly diversified portfolio of common stocks, equity REITs, midstream MLPs, and fixed income securities. Recent 3- and 5-year performance has been strong, matching or exceeding the S&P 500, though long-term returns lag the index slightly. The SCD fund is fairly valued at this time with an attractive yield and a discount.

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight the ten best CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select 10 CEFs every month from around 500 closed-end funds.

Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has successfully reached enrollment of 125 patients in the NEUTRALIZE-AKI pivotal clinical trial. Additionally, it has activated Methodist Hospital Metropolitan of San Antonio, Texas, as its 16th clinical trial site.

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.

NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.

SCD seeks total returns with a primary focus on income, investing globally in companies with strong fundamentals and clear market advantages. The fund uses leverage to enhance returns, with interest expenses expected to decline due to lower SOFR rates, improving cost efficiency. SCD's diversified portfolio spans equities, fixed income, and multiple sectors, offering a balanced approach with a 9.27% yield attractive for income investors.

NEW YORK--(BUSINESS WIRE)--Category: Distribution Related.

In a high-rate, volatility-prone market, strategies emphasizing resilient, income-generating sectors and tactical asset allocation can potentially help investors secure attractive yield and weather changes. Gain insight into ClearBridge Investments' strategy for equity and income from Portfolio Manager Peter Vanderlee. A Franklin Templeton company, ClearBridge Investments is a sub-advisor to LMP Capital and Income Fund Inc. (SCD), which seeks total return with an emphasis on income.

– R esearch supports combined use of EEG/ERP and vMRI for accurate differential diagnosis of SCD, MCI and dementia –

Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to

SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a new United States Department of Defense (DoD) grant has been awarded to AREVA. The grant is one of four selected out of 160 total submissions by the 2024 Military Burn Research Program (MBRP) and represents cutting-edge research for extracorporeal immunomodulation to reduce inflammation after severe burns, inhalation injury, and septicemia.

NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.

Heightened market volatility presents unique buying opportunities for income investors, particularly in the technology and energy sectors, which show signs of bottoming as Q1 earnings season approaches. LMP Capital and Income Fund Inc offers a 10% yield, trades at a discount to NAV, and recently increased its monthly distribution, making the SCD CEF an attractive buy. Despite recent market declines, SCD's long-term outlook remains positive due to its high-quality holdings, strong fundamentals, and potential for total return and dividend growth.